Delivery Order SPE2DB20D1109-SPE2DB22FP77J
- Not listed
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $2,440.50 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 1, 2022 with a completion date of February 2, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $1,409.52 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 29, 2023. The contract has a completion date of June 30, 2023 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $25,702.98 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 16, 2022 with a completion date of June 17, 2022. The contract is a delivery order issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of pharmaceutical products and...
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $11,069.30 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $17,401.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 19, 2024 and was awarded on November 18, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $6,131.46 delivery order is issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $7,587.56, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 13, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $7,624.06 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 7, 2021. The contract supports the DLA Troop Support Medical program and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite...
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $12,971.10 and a completion date of July 19, 2023. It is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $12,305.08 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FP77JDelivery Order
This federal contract award is for the delivery of Xarelto 20 mg tablets to the Defense Logistics Agency (DLA). The $19,404.28 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 4, 2022, with a completion date of August 5, 2022. This order is a part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that covers a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating full and open competition. AmerisourceBergen's parent company is Cencora, Inc., which also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.4k | 8/4/22 |